Perimenopausal conception

Annals of the New York Academy of Sciences

Volumn 997, Issue , 2003, Pages 93-104

  Tarlatzis, Basil C ^a,b   Zepiridis, Leonidas ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Geniki Kliniki   (Greece)

Author keywords

Embryo; Fertility potenial; Infertility; Ovary; Perimenopausal conception; Reproduction

Indexed keywords

AGE DISTRIBUTION; ANEUPLOIDY; BIOTECHNOLOGY; CHEMOTHERAPY; CONCEPTION; CONFERENCE PAPER; CRYOPRESERVATION; EARLY MENOPAUSE; ENDOCRINE FUNCTION; ENDOMETRIOSIS; ENVIRONMENTAL EXPOSURE; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LIFESPAN; MENOPAUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; OOCYTE; OOCYTE DONATION; OVARIECTOMY; OVARY FUNCTION; OVULATION INDUCTION; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREIMPLANTATION EMBRYO; PREMENOPAUSE; ADULT; AGE; CLIMACTERIUM; DRUG EFFECT; FEMALE; FERTILITY; FERTILIZATION; GREECE; HIGH RISK PREGNANCY; INCIDENCE; MATERNAL AGE; MIDDLE AGED; PHYSIOLOGY; PREGNANCY OUTCOME; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS;

ANIMALIA;

FERTILITY PROMOTING AGENT;

ADULT; AGE FACTORS; CLIMACTERIC; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; GREECE; HUMANS; INCIDENCE; INFERTILITY, FEMALE; MATERNAL AGE; MIDDLE AGED; OOCYTE DONATION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0642272543     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1290.011     Document Type: Conference Paper

References (82)

1. th ed. Williams and Wilkins. Baltimore, MD.
2. KAUFERT, P.A., P. GILBERT & R. TATE. 1987. Defining menopausal status: the impact of longitudinal data. Maturitas 9: 217-226.
3. WHELAN, E.A., D.P. SANDLER, D.R. MCCONNAUGHEY & C.R. WEINBERG. 1990. Menstrual and reproductive characteristics and age at natural menopause. Am. J. Epidemil. 131: 625-632.
4. TORGERSON, D.J., A. AVENELL, I.T. RUSSEL & D.M. REID. 1994. Factors associated with onset of menopause in women aged 45-49. Maturitas 19: 83-92.
5. TRELOAR, A.E., K.A. DO & N.G. MARTIN. 1998. Genetic influences on the age at meno-pause. Lancet 352: 1084-1085.
6. TE VELDE, E.R. & P. PEARSON. 2002. The variability of female reproductive ageing. Hum. Reprod. Update 8: 141-154.
7. SAUER, M.V., R.J. PAULSON & R.A. LOBO. 1992. Reversing the natural decline in human fertility: an extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA 268: 1275-1279.
8. SAUER, M.V., R.J. PAULSON & R.A. LOBO. 1993. Pregnancy after age 50: application of oocyte donation to women after natural menopause. Lancet 341: 321-323.
9. SAUER, V., R. PAULSON & R.A. LOBO. 1995. Pregnancy in women 50 or more years of age: outcome of 22 consecutive established pregnancies from oocyte donation. Fertil. Steril. 64: 111-115.
10. ASRM PRACTICE COMMITTEE. 2002. Aging and infertility in women 78: 215-219.
11. ABMA, J.C. et al. 1997. Fertility, family planning, and womens health: new data from the 1995 National Survey of Family Growth. Vital Health Stat. 23: 1-114.
12. HSUEH, A.J., H. BILIG & A. TSAFRIRi. 1994. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr. Rev. 15: 707-724.
13. DE BRUIN, J.P. et al. 2001. The role of genetic factors in age at natural menopause. Hum. Reprod. 16: 2014-2018.
14. VASKIVUO, T.E. et al. 2001. Survival of human follicles from fetal to adult life: apoptosis, apoptosis-related proteins, transcription factor GATA-4. J. Clin. Endocrinol. Metab. 86: 3421-3429.
15. CRISPONI, L. et al. 2001. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genet. 27: 159-166.
16. FADDY, M.J. et al. 1992. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 7: 1342-1346.
17. AITTOMAKI, K. et al. 1996. Clinical features of primary ovarian failure caused by a point mutation in the FSH-receptor gene. J. Clin. Endocrinol. Metab. 81: 3722-3726.
18. FADDY, M.J. & R.G. GOSDEN. 1996. A model conforming the decline in follicle numbers to the age of menopause in women. Hum. Reprod. 11: 1484-1486.
19. WEEL, A.E. et al. 1999. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J. Clin. Endocrinol. Metab. 84: 3146-3150.
20. SKOOG, I. et al. 1998. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J. Neurol. Neurosurg. Psychiatry 64: 37-43.
21. PEREZ, G.I. et al. 1999. Prolongation of ovarian lifespan into advanced chronological age by BAX-deficiency. Nature Genet. 21: 200-203.
22. GIANAROLI, L. et al. 1999. Preimplantation diagnosis for aneuploidies in patients undergoing IVF with poor prognosis: identification of the categories for which it should be proposed. Fertil. Steril. 72: 837-844.
23. PARISI, S. et al. 1999. Rec8p, a meiotic recombination and sister chromatid cohesion phosphoprotein of the Rad21p family conserved from fission yeast to humans. Mol. Cell. Biol. 19: 3515-3528.
24. WILCOX, A.J. et al. 1998. Post ovulatory ageing of the human oocyte and embryo failure. Hum. Reprod. 13: 394-397.
25. WELLS, D. & J.D. DELHANTY. 2000. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol. Hum. Reprod. 6: 1055-1062.
26. BATTAGLIA, D.E., P. GOODWIN, N.A. KLEIN & M.R. SOULES. 1996. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum. Reprod. 11: 2217-222.
27. ANGELL, R.R. 1994. Aneuploidy in older women. Higher rates of aneuploidy in oocytes from older women. Hum. Reprod. 9: 1199-2000.
28. TARIN, J.J. 1995. Aetiology of age related aneuploidy: a mechanism based on the free radical theory of ageing. Hum. Reprod. 10: 1563-1565.
29. GAULDEN, M.E. 1992. Maternal age effect: the enigma of Down's syndrome and other trisomic conditions. Mutat. Res. 296: 69-88.
30. HOLMAN, D.J. 1996. Total fecundability and fetal loss in Bangladesh. Ph.D. Thesis, Pennsylvania State University, University Park.
31. WISE, P.M. et al. 1999. Neuroendocrine influences and repercussions of the menopause. Endocr. Rev. 20: 243-248.
32. TRELOAR, A.E. et al. 1967. Variation of the menstrual cycle through reproductive life. Int. J. Fertil. 12: 77-126.
33. NASSERI, A. et al. 1999. Elevated serum day-3 FSH levels and/or estradiol may predict fetal aneuploidy. Fertil. Steril. 91: 312-317.
34. WELTMANN, A. et al. 1994. Relationship between age, percentage body fat, fitness and 24-hour growth hormone release in healthy young adults: effects of gender. J. Clin. Endocrinol. Metab. 78: 543-548.
35. GOSWAMY, P.K., G. WILLIAMS & P.C. STEPTOE. 1988. Decreased uterine perfusion - A cause of infertility. Hum. Reprod. 3: 955-959.
36. CROW, J. et al. 1994. Morphology and ultrastructure of fallopian tubes epithelium at different stages of the menstrual cycle and menopause. Hum. Reprod. 12: 2224-2233.
37. PSYCHOYOS, A. 1993. The high fertility of agonadal and amenorrhoeic women after oocyte donation. [Lett.] Hum. Reprod. 8: 498-499.
38. COHEN, M.A. et al. 1999. Reproductive outcome after sterilization reversal in women of advanced reproductive age. J. Assist. Reprod. Genet. 16: 402-404.
39. SAUER, M.V, R.J. PAULSON, B.A. ARY & R.A. LOBO. 1994. Three-hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J. Assist. Reprod. Genet. 11: 92-96.
40. MUNNE, S. et al. 1995. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil. Steril. 64: 382-391.
41. MUNNE, S. et al. 1999. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum. Reprod. 14: 2191-2199.
42. TONER, J.P. & J.T. FLOOD. 1993. Fertility after the age of 40. Obstet. Gynecol. Clin. North Am. 20: 261-272.
43. CORSON, S.L. 1998. Achieving and maintaining pregnancy after age 40. Int. J. Fertil. Womens Med. 43: 249-256.
44. TAN, S.L. et al. 1992. Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet 339: 1390-1394.
45. MARCUS, S.F. & P.R. BRINSDEN. 1996. IVF/ET in women aged 40 years and over. Hum. Reprod. Update 2: 459-468.
46. TARLATZIS, B.C., L. ZEPIRIDIS, G. GRIMBIZIS & J. BONTIS. 2003. Clinical management of low ovarian response to stimulation for IVF - A systematic review. Hum. Reprod. Update 9: 61-76.
47. SURREY, E.S. & W.B. SCHOOLCRAFT. 2000. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil. Steril. 73: 667-676.
48. KARANDE, V. & N. GLEICHER. 1999. A rational aproach to the management of low responders in IVF. Hum. Reprod. 14: 1744-1748.
49. HULL, M.G., C.F. FLEMING, A.O. HUGHES & A. MCDERMOTT. 1996. The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil. Steril. 65: 783-790.
50. TEMPLETON, A., J.K. MORRIS & W. PANSLOW. 1996. Factors that affect outcomeof invitro fertilisation treatment. Lancet 348: 1402-1406.
51. CENTERS FOR DISEASE CONTROL AND PREVENTION, AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE, SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY, RESOLVE. 2001. 1999 Assisted Reproductive Technology Success Rates. Centers for Disease Control and Prevention. Atlanta, GA.
52. LUTJEN, P.J. et al. (1984) The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 307: 174-176.
53. SERHAL, P. & I.L. CRAFT. 1989. Oocyte donation in 61 patients. Lancet i: 1185-1187.
54. SAUER, M.V. & R.J. PAULSON. 1990. Human oocyte and preembryo donation: an evolving method for the treatment of infertility. Am. J. Obstet. Gynecol. 163: 1421-1424.
55. ANTINORI, S. et al. 1993. Oocyte donation in menopausal women. Hum. Reprod. 8: 1487-1490.
56. PAULSON, R.J., I.E. HATCH, R.A. LOBO & M.V. SAUER. 1997. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum. Reprod. 12: 835-839.
57. HFEA. 2002. Provisional National Data Statistics in IVF (1999-2000).
58. EDWARDS, R.G. 1992. Why are agonadal and post-menopausal women so fertile after oocyte donation? [Edit.] Hum. Reprod. 7: 733-734.
59. EDWARDS, R.G. & S.F. MARCUS. 1995. Does a period of amenorrhoea raise subsequent chances of implantation in women? Curr. Sci. 68: 386-391.
60. FLAMIGNI, C. et al. 1993. Oocyte donation: comparison between recipients from different age groups. Hum. Reprod. 8: 2088-2092.
61. FLAMIGNI, C. 1993. Egg donation to women over 40 years of age. Hum. Reprod. 8: 1343-1344.
62. ROSENWAKS, Z. 1987. Donor eggs: their application in modern reproductive technologies. Fertil. Steril. 47: 895-909.
63. ROTSZTEJN, D.A. & R.H. ASCH. 1991. Effect of aging on assisted reproductive after technologies (ART): experience from egg donation. Semin. Reprod. EndocrinoL 9: 272-279.
64. SAUER, M.V., R.J. PAULSON & R.A. LOBO. 1990. A preliminary report on oocyte donation extending reproductive potential to women over 40. N. Engl. J. Med. 323: 1157-1160.
65. ABDALLA, H.I. et al. 1990. A report on 100 cycles of oocyte donation; factors affecting the outcome. Hum. Reprod. 5: 1018-1022.
66. ABDALLA, H.I. et al. 1998. Obstetric outcome in 232 ovum donation pregnancies. Br. J. Obstet. Gynaecol. 105: 332-337.
67. SODERSTROM-ANTILLA, V. 2001. Pregnancy outcome after oocyte donation. Hum. Reprod. Update 7: 28-32.
68. NEWTON, H. 1998. The cryopreservation of ovarian tissue as astrategy for preserving the fertility of cancer patients. Hum. Reprod. Update 4: 237-247.
69. CHEN, C. 1986. Pregnancy after human oocyte cryopreservation. Lancet i: 1884-1886.
70. PORKU, E. et al. 1997. Birth of a healthy female ICSI of cryopreserved human oocytes. Fertil. Steril. 68: 724-726.
71. AL-HASANI, S. et al. 1987. Cryopreservation of human oocytes. Hum. Reprod. 2: 965-700.
72. PICTON, H. 2002. Oocyte maturation in vitro. Curr. Opin. Obstet. Gynecol. 14: 295-302.
73. CHA, K.Y. & R.C. CHIAN. 1998. Maturation in vitro of immature human oocytes for clinical use. Hum. Reprod. Update 4: 103-120.
74. TROUNSON, A., C. ANDERIESZ & G. JONES. 2001. Maturation of human oocytes in vitro and their developmental competence. Reproduction 121: 51-75.
75. CHA, K.Y. et al. 2000. Freezing immature oocytes. Mol. Cell. Endocrinol. 169: 43-47.
76. DONNEZ, J. & S. BASIL. 1998. Indications for cryopreservation of ovarian tissue. Hum. Reprod. Update 4: 248-259.
77. GOSDEN, R.G. et al. 1994. Restoration of fertility to oophorectomized sheep by ovarian tissue autografts stored at -196°C. Hum. Reprod. 9: 597-603.
78. GOSDEN, R.G., M. BOULTON, R. GRANT & R. WEBB. 1994. Follicular development for ovarian xenografts in SCID mice. J. Reprod. Fertil. 101: 619-623.
79. WOOD, C.E. et al. 1997. Cryopreservation of ovarian tissue: potential "reproductive insurance" for women at risk of early ovarian failure. Med. J. Aust. 166: 366-369.
80. TUCKER, M.J. et al. 1998. Birth after cryopreservation of immature oocytes with subsequent IVM. Fertil. Steril. 70: 578-579.
81. OKTAY, K. et al. 1998. Cryopreservation of immature human oocytes and ovarian tissue - An emerging technology? Fertil. Steril. 69: 1-7.
82. ZHANG, J. et al. 1999. In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer. Fertil. Steril. 71: 726-731.